Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Esperance Anne Kreek Schaefer, M.D.

Co-Author

This page shows the publications co-authored by Esperance Schaefer and Raymond Chung.
Connection Strength

5.422
  1. Interrelationship Between Coronavirus Infection and Liver Disease. Clin Liver Dis (Hoboken). 2020 May; 15(5):175-180.
    View in: PubMed
    Score: 0.898
  2. Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C. World J Gastroenterol. 2016 Dec 07; 22(45):9954-9965.
    View in: PubMed
    Score: 0.707
  3. HCV and host lipids: an intimate connection. Semin Liver Dis. 2013 Nov; 33(4):358-68.
    View in: PubMed
    Score: 0.572
  4. Anti-hepatitis C virus drugs in development. Gastroenterology. 2012 May; 142(6):1340-1350.e1.
    View in: PubMed
    Score: 0.514
  5. The impact of human gene polymorphisms on HCV infection and disease outcome. Semin Liver Dis. 2011 Nov; 31(4):375-86.
    View in: PubMed
    Score: 0.501
  6. Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase. Cell Mol Gastroenterol Hepatol. 2021; 12(4):1297-1310.
    View in: PubMed
    Score: 0.242
  7. Microrna-130a Downregulates HCV Replication through an atg5-Dependent Autophagy Pathway. Cells. 2019 04 10; 8(4).
    View in: PubMed
    Score: 0.208
  8. A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6. Hepatology. 2019 03; 69(3):1004-1019.
    View in: PubMed
    Score: 0.206
  9. MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway. J Virol. 2018 04 01; 92(7).
    View in: PubMed
    Score: 0.193
  10. Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types. Hepatology. 2016 12; 64(6):1951-1968.
    View in: PubMed
    Score: 0.175
  11. IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-?B pathway. J Hepatol. 2016 11; 65(5):972-979.
    View in: PubMed
    Score: 0.172
  12. HCV induces transforming growth factor ß1 through activation of endoplasmic reticulum stress and the unfolded protein response. Sci Rep. 2016 Mar 01; 6:22487.
    View in: PubMed
    Score: 0.168
  13. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway. J Virol. 2015 Jul; 89(13):6608-18.
    View in: PubMed
    Score: 0.158
  14. The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing. J Hepatol. 2015 May; 62(5):1024-32.
    View in: PubMed
    Score: 0.154
  15. Kinetic differences in the induction of interferon stimulated genes by interferon-a and interleukin 28B are altered by infection with hepatitis C virus. Hepatology. 2014 Apr; 59(4):1250-61.
    View in: PubMed
    Score: 0.146
  16. The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-ß signaling. J Hepatol. 2013 Nov; 59(5):942-8.
    View in: PubMed
    Score: 0.139
  17. Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase. J Infect Dis. 2011 Aug 15; 204(4):609-16.
    View in: PubMed
    Score: 0.122
  18. Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection. J Infect Dis. 2018 09 22; 218(9):1394-1403.
    View in: PubMed
    Score: 0.050
  19. A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell. 2013 Feb 07; 12(2):238-51.
    View in: PubMed
    Score: 0.034
  20. Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling. J Virol. 2012 Aug; 86(16):8581-91.
    View in: PubMed
    Score: 0.032
  21. Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus. J Am Chem Soc. 2012 Apr 25; 134(16):6896-9.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.